Levels of cyclin A, D, and E were analyzed, as well as phosphorylated CDK2 and total CDK2 (Supplemental Fig. 5A, C, Fig. 4a), in tumor lysates that were either cisplatin-sensitive (parental) or cisplatin-resistant. Here, CDK2 is linked to neoplasm.